STANDARD OPERATING PROCEDURE

Size: px
Start display at page:

Download "STANDARD OPERATING PROCEDURE"

Transcription

1 STANDARD OPERATING PROCEDURE Title Reference Number Training and Development SOP-QMS-007 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Teresa O Leary, Head of Regulatory Compliance Melanie Boulter, QA Auditor Authorisation (Original signatures are retained by Research & Innovation) Dr Stephen Ryder Director of Research & Innovation Dr Stephen Fowlie Medical Director 04 Apr Apr 2016 USERS OF THIS STANDARD OPERATING PROCEDURE MUST REFER TO TO ENSURE THE MOST CURRENT VERSION IS BEING USED

2 Page 2 of 9 1. Document History Version Issue Date Reason for Change Number 1 30 th May 2014 Original SOP. Replaces SOP-19. Updated due to actions from CAPA 15/04 and 2 15 Apr 2016 biennial review

3 Page 3 of 9 2. Introduction The Medicines for Human Use (Clinical Trials) Regulations 2004 states that each individual involved in conducting a trial shall be qualified by education, training and experience. The Council Directive 93/42/EEC on Medical Devices (MDD) (1993) states the devices must be designed and manufactured in such a way that, when used under the conditions and for the purposes intended, they will not compromise the clinical condition or the safety of patients, or the safety and health of users or, where applicable, other persons, provided that any risks which may be associated with their intended use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety. This shall include: Consideration of the technical knowledge, experience, education and training and where applicable the medical and physical conditions of intended users (design for lay, professional, disabled or other users). Therefore, for NUH sponsored clinical trials of investigational medicinal products (CTIMPs) and clinical medical devices (CMD) appropriate training of research staff must be ensured. 3. Purpose and Scope The purpose of this standard operating procedure (SOP) is to describe the training processes and training requirements which apply to NUH R&I sponsored research. This SOP applies to NUH R&I staff and research teams involved in sponsored CTIMPs and CMD studies. 4. Responsibilities Sponsor (fulfilled by the Research and Innovation (R&I) department on behalf of NUH as sponsor) Sponsor and Chief Investigator (CI) or Principal Investigator (PI) will be responsible for ensuring all members of their research team have adequate levels of training for the studies they are working on. Research and Innovation (R&I) Head of Regulatory Compliance Ensures GCP processes are implemented through standard operating procedures and are managed through documentation control process. Responsible for the training management and maintains the role based training matrix.

4 Page 4 of 9 5. Definitions CI CRN CV GCP HR HRA ISF NIHR NUH PI QA R&I RPM SOP TMF Chief Investigator Clinical Research Network Curriculum Vitae Good Clinical Practice Human Resources Health Research Authority Investigator Site File National Institute for Health Research Nottingham University Hospitals NHS Trust Principal Investigator Quality Assurance Research and Innovation Research Project Manager Standard Operating Procedure Technical Master File

5 Page 5 of 9 6. Procedure 6.1 Training Management Role based training is managed through a training requirements matrix. The training matrix is managed by the Head of Regulatory Compliance (HRC) and is a controlled document (password protected). Within the training matrix, all NUH R&I and research team roles are identified and a set of training requirements assigned to each role. Addition or removal of any role or training requirement is controlled by the HRC. The training methods on the R&I induction programmes and SOPs are defined as Awareness (A) and Read & Understand /Classroom (Y), and are role based. Training effectiveness for classroom training is managed through training provider certification. Training is assessed through audits, study monitoring and reported to R&I management through QA metrics. 6.2 NUH R&I Staff New Staff All new R&I staff members must attend the required NUH corporate induction. The R&I specific research induction and safety training is mandatory and is arranged by the HRC. Each R&I line manager must inform the HRC of new inductees start dates in order to schedule this training. The new member of staff must complete the required R&I SOP training within the first month of starting. R&I staff directly involved in CTIMPs and CMD studies must complete the required GCP training which is facilitated by the National Institute for Health Research (NIHR). This training requirement is managed by each individual and is recorded in personal training folders. The HRC will provide the booking information to the new employee.

6 Page 6 of Refresher Training All R&I staff members must complete refresher NUH corporate training on a yearly basis (birth month). The R&I safety training is an annual refresher training and is completed within 12 months of the last training session. This is managed and arranged by the HRC. GCP refresher training is completed every two years and facilitated by the NIHR. This training requirement is managed by each individual and is recorded in personal training folders New Training Requirements Updated training requirements e.g. revised SOPs will be issued for training by the HRC. All R&I staff are responsible for ensuring they have completed all the required training as per the training matrix Classroom Training For R&I delivered classroom training, attendance must be recorded using the training attendance log (TAFQ00803) or the service provider training attendance form. The attendance logs are stored in a dedicated classroom training folder located with the HRC/QAA office SOP Training SOP training must be recorded using the SOP signature log (TAFQ00701). The SOP signature logs are stored in the master SOP folders located with the HRC/QAA office. The process for SOP review, approval and training is detailed with SOP_QMS_ R&I Personnel Training Folders Each member of R&I team are allocated with a dedicated personal training folder. This folder contains the following: Recent CV (signed and dated) (HRA template); GCP or other research/regulatory training certification; Role specific training and certificates; Current job description (signed by the employee and their line manager). For leavers, the personal training folder content will be archived within the individual s HR file.

7 Page 7 of Research Study Training (CTIMPs and CMDs) Research studies (CTIMPs and CMDs) The research team involved in the study must complete R&I induction training, this is only required for research personnel new to clinical research. The research team involved in the study must complete R&I safety reporting training, this is only required for research personnel new to clinical research. Prior to sponsorship authorisation of a study, up to date CVs (using HRA template) must be provided to the sponsor (NUH R&I) to ensure CI/PI and research teams have the appropriate clinical research skills. All research staff must complete GCP training or have valid GCP training certification. The R&I RPM must issue the training matrix and SOPs (applicable) to the CI/PI (to each PI when multi-site) along with the SOP signature logs (TAFQ00701). The CI/PI must then ensure all the mandatory training is completed and training is recorded in the SOP signature logs. The signed SOP signature logs must be filed within ISF (Investigator Site File) and a copy provide to sponsor for filing in the Technical Master File (TMF) Research Teams (Others) For research studies which are not classed as CTIMPs or CMDs, R&I SOP training is not dependant on the risk of the study and should be assessed as part of the risk assessment process (SOP-RES-002). However, for studies requiring informed consent training on SOP-RES-015 should be completed by the CI/PI and research teams involved in patient consent Site Initiation Visit (SIV) During initial study setup a site initiation training session will performed and recorded by the R&I RPM. This session will provide an overview of the mandatory requirements to conduct and manage the research study. During the SIV, the R&I RPM will verify that all mandatory SOP, GCP and any other required training has been completed. Until such training has been verified, the research cannot commence. Delegated activities must be proportional to the training and skills of the individual i.e. no one should perform research activities without the appropriate training.

8 Page 8 of Training Records All training records e.g. GCP Certs, CVs, SOP signature logs must be stored within the ISF (Investigator Site File) and copies filed in the TMF (Trial Master File). Training records which are superseded must be marked as such and retained within ISF and/or TMF. All ISFs and TMFs will be archived according to SOP_RES_ New or Revised Mandatory SOP Training New or revised SOPs will be issued for training to the CI/PI along with the training matrix. The CI/PI is responsible for ensuring the research team complete the training within the training period i.e. 30 working days. If training is not completed within the training period, no research activity related to the new/revised SOP must be performed. The CI/PI must store training records within the ISF and provide copies to the R&I RPM for filing in the TMF. The R&I RPM will review training completion through monitoring CTU Managed Studies For NCTU (Nottingham Clinical Trials Unit) managed studies, the Trial Manager is responsible for ensuring training is completed and up to date. R&I research induction training is not mandatory for NCTU managed trials however, this can be performed if requested. For non CTIMP and low risk medical devices trials, the NCTU Trial Manual will act as the official procedure for research management and conduct. This must be agreed with NUH R&I as sponsor. Where the Trial Manual and the Sponsor (NUH R&I) SOPs are required, the Trial Manager will be issued with the training matrix and SOPs by the R&I RPM. The Trial Manager is responsible for ensuring training is recorded. Training records must be stored in the ISF and NCTU TMF with copies provided to the R&I RPM for recording in the TMF.

9 Page 9 of 9 7. References and Associated Documents Research Governance Framework for Health and Social Care: Second Edition, 2005 The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent amendments International Conference on Harmonisation Guidelines for Good Clinical Practice E6 (R1) The Medical Devices Regulations 2002 and subsequent amendments ISO Clinical Investigation of Medical Devices for Human Subjects TAFQ00701 SOP-QMS-001 SOP-QMS-002 SOP-RES-002 SOP-RES-015 SOP_RES_028 CV Standard Operating Procedure Signature Log Preparation, Review and Approval of Standard Operating Procedures Document Version Control Risk Assessment Informed Consent Archiving and Destruction of Records Curriculum Vitae Template from the HRA website

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Archiving and the Destruction of Records SOP-RES-028 Version Number 2 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review Date 22 nd January

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Trial Master File & Investigator Site File SOP number: TM 001 SOP category: Trial Management Version number: 03 Version

More information

Standard Operating Procedure for Archiving

Standard Operating Procedure for Archiving Standard Operating Procedure for Archiving SOP name: NWORTH07/19 archiving Version 2 Authorship Team: Angela Gliddon & Rhiannon Whitaker Meeting date reviewed 16 th April 2008 Designated NWORTH member

More information

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no: Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved

More information

STANDARD OPERATING PROCEDURE SOP 310

STANDARD OPERATING PROCEDURE SOP 310 STANDARD OPERATING PROCEDURE SOP 310 DEVELOPMENT OF PARTICIPANT INFORMATION SHEET AND INFORMED CONSENT FORM Version 1.3 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 8 Review date April

More information

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products 1 Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products SECTION TITLE DOCUMENTS 1. Contact List Including details of relevant study site staff, responsible

More information

Study Files and Filing

Study Files and Filing Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm

More information

STUDY CLOSURE AND ARCHIVING

STUDY CLOSURE AND ARCHIVING STUDY CLOSURE AND ARCHIVING DOCUMENT NO.: CR009 v2.0 AUTHOR: Lynn Smith ISSUE DATE: 15 August 2016 EFFECTIVE DATE: 29 August 2016 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research

More information

Computer System Validation & Backup

Computer System Validation & Backup REFERENCE: VERSION NUMBER: 1.1 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager, Clinical Trials Officer REVIEWED BY: R&I Senior Team APPROVED BY: Deputy Director of Research

More information

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document SOP Title: Investigator s Brochure Content, Design, Amendments, Filing & Distribution Author: Clinical Research and Development Office (CRDO) Author Signature: Date: 10 October 2017 The author is signing

More information

IMP Management and Accountability

IMP Management and Accountability This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

Confirming Research Study Capacity and Capability

Confirming Research Study Capacity and Capability Title: Outcome Statement: Written By: Confirming Research Study Capacity and Capability Researchers will be informed about the procedures and requirements for obtaining permission to conduct a research

More information

Inspections: an academic perspective

Inspections: an academic perspective Inspections: an academic perspective Patricia Henley Quality and Governance Manager Head, Research Governance & Integrity Office London School of Hygiene & Tropical Medicine Email: patricia.henley@lshtm.ac.uk

More information

GCP Basics - refresher

GCP Basics - refresher p. 01 GCP Basics - refresher Agenda: p. 02 Brief History of GCP GCP Regulations Principles of ICH E6 Sponsor Responsibilities Computer Systems Common Compliance Issues Brief History of GCP 3 Brief History

More information

Trial oversight SOP for HEY-sponsored CTIMPs

Trial oversight SOP for HEY-sponsored CTIMPs R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system

More information

ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies

ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies SOP number: ECTU TM 17 Signature Date Authored by: Holly Ennis, Trial Manager 6 th Sept 2017 Reviewed by: Laura Forsyth, Trial Manager

More information

Sponsorship of Clinical Research Studies

Sponsorship of Clinical Research Studies Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use

More information

NIHR Guideline B01 R&D Operational Capability Statement - Colchester Hospital University NHS Foundation Trust

NIHR Guideline B01 R&D Operational Capability Statement - Colchester Hospital University NHS Foundation Trust NIHR Guideline B01 R&D Operational Capability Statement - Colchester Hospital University NHS Foundation Trust Note: This spreadsheet is protected to help avoid inadvertent changes. However there is no

More information

The European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:

The European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: The European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197221/2005 Procedure no.: INS/GCP/3/IV ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: SPONSOR

More information

OECD and EPA GLP Differences

OECD and EPA GLP Differences OECD and EPA GLP Differences Annette Leslie RQAP-GLP Du Pont Pioneer Ankeny Iowa I conduct studies in the US, so Why do I care about oecd regulations? Disclaimer: I cannot cover all the differences in

More information

Quality Site Visit Report FGK Clinical Research (FGK) GmbH, Munich Germany. Audit No. CT6018. Date of Audit: 3rd to 5th May 2017

Quality Site Visit Report FGK Clinical Research (FGK) GmbH, Munich Germany. Audit No. CT6018. Date of Audit: 3rd to 5th May 2017 Quality Site Visit Report FGK Clinical Research (FGK) GmbH, Munich Germany Head Office Address FGK Clinical Research GmbH Heimeranstrasse 35, 80339 Munich, Germany Research Centre Address FGK Clinical

More information

How to Apply for Ethics (Non-CTIMPs) including Sponsorship

How to Apply for Ethics (Non-CTIMPs) including Sponsorship How to Apply for Ethics (Non-CTIMPs) including Sponsorship Joint Research & Enterprise Office (JREO) St George s University of London Lucy H H Parker Clinical Research Governance Manager Joint Research

More information

Quality Assurance in Clinical Trials

Quality Assurance in Clinical Trials Quality Assurance in Clinical Trials Doctor Catherine CORNU, Lyon clinical Investigation Centre EUDIPHARM December 5th, 2011 1 Introduction: quality in clinical research in human subjects Regulatory requirements:

More information

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials 1 2 3 4 5 6 7 1 February 2013 EMA/INS/GCP/636736/2012 Good Clinical Practice Inspectors Working Group (GCP IWG) Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic)

More information

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents Guidance for s Regulatory File Essential s All principal investigators must maintain a regulatory binder or file system, which contains all study documentation. These records may be reviewed at the time

More information

Human Research Audit Program. Gabrielle Gaspard, MPH, CCRC Assistant Director, Human Research Compliance

Human Research Audit Program. Gabrielle Gaspard, MPH, CCRC Assistant Director, Human Research Compliance Human Research Audit Program Gabrielle Gaspard, MPH, CCRC Assistant Director, Human Research Compliance Monday, September 11, 2017 Objectives 1. Understand the purpose of the audit program 2. Identify

More information

Audit Program Background Definition Management Example Content Risk assessment approach

Audit Program Background Definition Management Example Content Risk assessment approach AUDIT PROGRAM Audit Program Background Definition Management Example Content System audits vs study audits Risk assessment approach ICH-GCP E6 new content Management Example 2 Background - Definition There

More information

Standard Operating Procedure (SOP)

Standard Operating Procedure (SOP) Standard Operating Procedure VALIDATION AND BACKUP OF COMPUTER SYSTEMS USED IN RESEARCH SETTING AUDIENCE ISSUE Trustwide Chief Investigators and associated Research Staff setting up and managing clinical

More information

Recording, Managing and Reporting Adverse Events in the UK

Recording, Managing and Reporting Adverse Events in the UK This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

1 The Clinical Research Coordinator (CRC)... 1

1 The Clinical Research Coordinator (CRC)... 1 TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...

More information

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations 9th edition of Synevo Clinical Research Symposium. 17 th November 2017 Bucharest.

More information

COMPUTER SYSTEMS VALIDATION

COMPUTER SYSTEMS VALIDATION COMPUTER SYSTEMS VALIDATION DOCUMENT NO.: POL007 v1.0 AUTHOR: Lorn Mackenzie ISSUE DATE: 04 AUG 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint

More information

PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector

PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector Content Answer industry questions related to the PSMF MHRA inspector s preparation: How we

More information

RISK MANAGEMENT COMMITTEE TERMS OF REFERENCE

RISK MANAGEMENT COMMITTEE TERMS OF REFERENCE RISK MANAGEMENT COMMITTEE TERMS OF REFERENCE Terms of Reference Agreed by the Committee Signed by the Chair on Behalf of the Committee Print Signature Date 16 th December 2011 Review Date December 2012

More information

Burton Hospitals NHS Foundation Trust. On: 22 January Review Date: December Corporate / Directorate. Department Responsible for Review:

Burton Hospitals NHS Foundation Trust. On: 22 January Review Date: December Corporate / Directorate. Department Responsible for Review: POLICY DOCUMENT Burton Hospitals NHS Foundation Trust DATA QUALITY POLICY Approved by: Trust Management Team On: 22 January 2016 Review Date: December 2018 Corporate / Directorate Clinical / Non Clinical

More information

Quality Management. at Clinical Research Center (CRC) Hannover : Concepts and Experiences in Early Phase Clinical Trials

Quality Management. at Clinical Research Center (CRC) Hannover : Concepts and Experiences in Early Phase Clinical Trials Arbeitsgemeinschaft für angewandte Humanpharmakologie e.v. Association for Applied Human Pharmacology in Early Phase Clinical Pharmacology Units AGAH Workshop, Bonn, 03/04 Nov. 2016 : Concepts and in Early

More information

DATA QUALITY POLICY Review Date: CONTENT

DATA QUALITY POLICY Review Date: CONTENT Title: Date Approved: Approved by: DATA QUALITY POLICY Review Date: Policy Ref: Issue: Jan 2010 Sherwood Forest Hospitals Oct 2011 Information Governance Group Division/Department: Policy Category: ISP_03

More information

Standard Operating Procedures (SOPs) to achieve Good Clinical Practice (GCP) in Australian Clinical Research

Standard Operating Procedures (SOPs) to achieve Good Clinical Practice (GCP) in Australian Clinical Research Standard Operating Procedures (SOPs) to achieve Good Clinical Practice (GCP) in Australian Clinical Research September 2007 Version 1.0 Prepared by Nucleus Network on behalf of VMIA Introduction to the

More information

Standard Operating Procedures (SOPs)

Standard Operating Procedures (SOPs) Organizational Strategies for Clinical Trials Standard Operating Procedures (SOPs) SUSAN JACKSON, MPA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE UNC CENTER

More information

MRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council

MRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR

More information

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Copyright 2009 - Pharmaceutical Research & Manufacturers Association 1 Overview Audit ICH-GCP,

More information

BIM CERTIFIED QUALITY AQUACULTURE (CQA) SCHEME DOCUMENT CONTROL

BIM CERTIFIED QUALITY AQUACULTURE (CQA) SCHEME DOCUMENT CONTROL BIM CERTIFIED QUALITY AQUACULTURE (CQA) SCHEME DOCUMENT CONTROL PURPOSE This procedure describes the method by which the controlled copies of the BIM CQA Quality System Documents are issued and maintained

More information

Multi-Site Coordination Process. Drafted by: Ester Dimayuga Page 1 of 18

Multi-Site Coordination Process. Drafted by: Ester Dimayuga Page 1 of 18 Multi-Site Coordination Process Drafted by: Ester Dimayuga Page 1 of 18 MULTI-SITE COORDIATIO (MSC) REGULATOR PROCESS CTO-Regulatory notifies MSC of trial with UMCC as coordinating center MSC prepares

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland Question 1: What laws or regulations apply to an application for conducting a clinical

More information

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee) Page 1 of 8 Hospital Authority (HA) Guide on Research Ethics (for Study Site & Version Effective Date 2 01/02/2015 Document Number HAHO-CE&TM-HA REC Author HA Head Office Steering Committee on Research

More information

Comparison of admission rates to neonatal units between PO screening and non-po screening Units

Comparison of admission rates to neonatal units between PO screening and non-po screening Units London - Westminster Research Ethics Committee 4 Minshull Street Manchester M1 3DZ Telephone: 0207 104 8012 Please note: This is the favourable opinion of the REC only and does not allow you to start your

More information

Standard Operating Procedures Guidelines for Good Clinical Practice

Standard Operating Procedures Guidelines for Good Clinical Practice SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA

More information

Regulatory and ethical requirements in medical device studies. Finland

Regulatory and ethical requirements in medical device studies. Finland Regulatory and ethical in medical device studies Finland SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within

More information

RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT

RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT JAN SINGLETON RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT Research is what I'm doing when I don't know what I'm doing. ~Wernher Von Braun When are you approved to commence your research? Your study has

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Creation & Maintenance of an Investigator Brochure SOP Number: 34 Version Number: 1.0 Supercedes: N/A Effective date: August

More information

Reflection paper on guidance for laboratories that perform the analysis or evaluation of clinical trial samples

Reflection paper on guidance for laboratories that perform the analysis or evaluation of clinical trial samples 1 2 3 26 August 2010 EMA/INS/GCP/532137/2010 GCP Inspectors Working Group 4 5 6 Reflection paper on guidance for laboratories that perform the analysis or evaluation of clinical trial samples Draft Adoption

More information

5 th Training Workshop for Micro-, Small- and Medium- Sized Enterprises (SMEs)

5 th Training Workshop for Micro-, Small- and Medium- Sized Enterprises (SMEs) 5 th Training Workshop for Micro-, Small- and Medium- Sized Enterprises (SMEs) GCP Requirements and Compliance Dr. Katalina Mettke BfArM, Germany Agenda Specialities of Early Development Trials Examples

More information

SOP04: Standard Operating Procedure for Trial Supplies and Labelling

SOP04: Standard Operating Procedure for Trial Supplies and Labelling SOP04: Standard Operating Procedure for Trial Supplies and Labelling Authorship Team: Anne Seagrove & Mair Roberts Joint SOP Group on Trial Administration (viz Angela Evans, Sarah Gaze, Hayley Hutchings,

More information

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor. SOP #: RCO-100 Page: 1 of 11 1. POLICY STATEMENT: An Overall Principal Investigator (PI) who holds an Investigational New Drug Application (IND) and who is the Sponsor of the research has additional responsibilities

More information

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual The StAmP Trial: A Proof of Principle, double blind, Randomised Placebo-Controlled, Multi Centre Trial of Statins to Ameliorate Early Onset Pre-eclampsia. ISRCTN: 23410175 EudraCT Number: 2009-012968-13

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical

More information

TRAINING AND DEVELOPMENT POLICY AND PROCEDURE ISO 9001:2008 Clause 6.2.2

TRAINING AND DEVELOPMENT POLICY AND PROCEDURE ISO 9001:2008 Clause 6.2.2 TRAINING AND DEVELOPMENT POLICY AND PROCEDURE ISO 9001:2008 Clause 6.2.2 Approvals The signatures below certify that this procedure has been reviewed and accepted, and demonstrates that the signatories

More information

Good Clinical Practice

Good Clinical Practice Dublin Academic Medical Centre Good Clinical Practice Patrick Murray, MD, FASN, FRCPI Professor, University College Dublin, Mater Misericordiae University Hospital, Dublin, Ireland patrick.murray@ucd.ie

More information

DATA QUALITY POLICY. Version: 1.2. Management and Caldicott Committee. Date approved: 02 February Governance Lead

DATA QUALITY POLICY. Version: 1.2. Management and Caldicott Committee. Date approved: 02 February Governance Lead DATA QUALITY POLICY Version: 1.2 Approved by: Date approved: 02 February 2016 Name of Originator/Author: Name of Responsible Committee/Individual: Information Governance, Records Management and Caldicott

More information

HSCIC Audit of Data Sharing Activities:

HSCIC Audit of Data Sharing Activities: Directorate / Programme Data Dissemination Services Project Data Sharing Audits Status Approved Director Terry Hill Version 1.0 Owner Rob Shaw Version issue date 20/04/2016 HSCIC Audit of Data Sharing

More information

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Quality Assurance QA 601.01 STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick

More information

OCTC 2012 CRO Selection

OCTC 2012 CRO Selection OCTC 2012 CRO Selection Colin Macaulay Viron Therapeutics Inc. 15 Nov 2012 Viron Therapeutics Inc. Virtual Biotech Company (6) Phase 2a (48 pt) clinical trial in acute coronary syndrome (ACS) completed

More information

System Requirements (URS)

System Requirements (URS) System s (URS) System Document Control System Document ID URS000XXX Version 1 DOCUMENT APPROVALS Reason For Signature Name Position Signature Date Prepared by Vic Johnson Project Manager Checked for accuracy

More information

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience Umberto Filibeck Former Head of AIFA GCP Inspectorate and GCP Promotion Unit UNICRI Consultant for Projects on GCP of CTs in developing

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

HRA Statement of Activities

HRA Statement of Activities HRA Statement of Activities for Participating NHS Organisations in England (template version 4.0) For non-commercial studies, one Statement of Activities should be completed as a template for each site

More information

NIHR Local Clinical Research Networks

NIHR Local Clinical Research Networks NIHR Local Clinical Research Networks Annual Plans 2014-15 Guidance WORKING DRAFT Version 0.4 WORKING DRAFT v0.4 Document Control This document is updated and issued annually by the national CRN Coordinating

More information

THE IPSWICH HOSPITAL NHS TRUST. Divisional Board. TERMS OF REFERENCE Version 1.0

THE IPSWICH HOSPITAL NHS TRUST. Divisional Board. TERMS OF REFERENCE Version 1.0 THE IPSWICH HOSPITAL NHS TRUST Divisional Board TERMS OF REFERENCE Version 1.0 Purpose: For use by: This document is compliant with /supports compliance with: This document supersedes: Approved by: To

More information

Essential Healthcare Research Governance Processes. Cindy Cooper, Lindsay Unwin and Judith Cohen, UoS

Essential Healthcare Research Governance Processes. Cindy Cooper, Lindsay Unwin and Judith Cohen, UoS Essential Healthcare Research Governance Processes Cindy Cooper, Lindsay Unwin and Judith Cohen, UoS Aims Overview of governance processes including recent changes to remit Reminder of HoD and PI responsibilities

More information

FDA Sponsor and Investigator Responsibility Checklist

FDA Sponsor and Investigator Responsibility Checklist FDA Sponsor and Investigator Responsibility Checklist Principal Investigator: Study Name: CPHS #: IND/IDE #: Name of IND/IDE holder: The following checklist is created based on the Sponsor and Investigator

More information

NHSLA Risk Management Standards for NHS Trusts Providing Community Services 2011/12

NHSLA Risk Management Standards for NHS Trusts Providing Community Services 2011/12 NHSLA Risk Management Standards for NHS Trusts Providing Community Services 2011/12 Milton Keynes Primary Care Trust Provider of Community and Mental Health Services Level 1 May 2011 Contents Page 1: Executive

More information

Quality Management System. Manual MASTER COPY

Quality Management System. Manual MASTER COPY Quality Management System Manual MASTER COPY Revisions: Date Summary Rev. July 2010 14 Oct 2010 28 Jan 2011 9 Feb 2011 9 June 2011 6 March 2012 11 July 2013 13 July 2017 Initial Draft Issued Minor changes

More information

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework 1 Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework Mandy Morneault Research Compliance Monitor University of Washington Institute of Translational Health

More information

Standard Operating Procedure for Statistical Reports

Standard Operating Procedure for Statistical Reports Reports_V01.doc Page 1 of 6 Standard Operating Procedure for Statistical Reports SOP ID Number: Effective Date: 22/01/2010 Version Number & Date of Authorisation: V01,15/01/2010 Review Date: 22/01/2012

More information

Technical Services Document #: TS-0007 Internal Audit Procedure Version #: 01

Technical Services Document #: TS-0007 Internal Audit Procedure Version #: 01 1. Purpose The purpose of this procedure is to define the process used to manage the Internal Audits of the Quality Management System for Technical Services. 2. Scope This procedure applies to all Internal

More information

ISO 9001:2015 Internal Audit Checklist 7.0 Support

ISO 9001:2015 Internal Audit Checklist 7.0 Support The internal audit checklist is just one of the many tools available from the auditor s toolbox. The checklist ensures each audit concisely compares the requirements of ISO 9001:2015, and your Quality

More information

NOTICE OF SUBSTANTIAL AMENDMENT

NOTICE OF SUBSTANTIAL AMENDMENT NOTICE OF SUBSTANTIAL AMENDMENT For use in the case of all research other than clinical trials of investigational medicinal products (CTIMPs). For substantial amendments to CTIMPs, please use the EU-approved

More information

Primary Care mcta 2013: Guidance for use

Primary Care mcta 2013: Guidance for use GUIDANCE ON USE OF THE MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY SPONSORED RESEARCH IN PRIMARY CARE (PRIMARY CARE mcta, 2013 VERSION) Background to the development

More information

Source And Regulatory Documentation for DMID Clinical Studies

Source And Regulatory Documentation for DMID Clinical Studies Source And Regulatory Documentation for DMID Clinical Studies Walt Jones RN, MPH Nurse Consultant Clinical Monitoring Coordinator OCRA, DMID, NIAID November, 2007 Source Data Defined All information in

More information

Objectives. The Regulatory Binder = Investigator Site File= Trial Center File 8/16/2010. Essential Documents: Maintaining the Site's Regulatory Binder

Objectives. The Regulatory Binder = Investigator Site File= Trial Center File 8/16/2010. Essential Documents: Maintaining the Site's Regulatory Binder Essential Documents: Maintaining the Site's Regulatory Binder How to Manage the Essential Documents for the Investigator and Study Site Objectives Describe the importance of maintaining the Regulatory

More information

Regulatory and ethical requirements in medical devices studies. France

Regulatory and ethical requirements in medical devices studies. France Regulatory and ethical in medical devices studies France SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within

More information

Quality Audit Report. Name of Auditee Auditee Address. Audit No. CT 5500

Quality Audit Report. Name of Auditee Auditee Address. Audit No. CT 5500 Quality Audit Report Name of Auditee Auditee Address Audit No. CT 5500 Date of Audit: 9 th -12 th January 2017 Head Office Address xxxxxx xxxxxx Research Centre Address xxxxxx xxxxxx Protocol Titles:Not

More information

INFORMATION GOVERNANCE POLICY

INFORMATION GOVERNANCE POLICY INFORMATION GOVERNANCE POLICY Page 1 of 13 INFORMATION GOVERNANCE POLICY EXECUTIVE SUMMARY Key Messages Principles of Information Governance Openness Confidentiality and Legal Compliance Information Security

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

A step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC.

A step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC. A step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC. 28 June 2017 Summary All project-based research conducted in or through the NHS/HSC in England, Northern Ireland,

More information

Human Samples in Research

Human Samples in Research Human Samples in Research Import and Export of Human Tissue Document Identifier HTA-06-SOP-Import and Export AUTHOR APPROVER EFFECTIVE DATE: Name and role Signature and date Name and role Signature and

More information

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE 1. PURPOSE The purpose of this SOP is to define the minimum requirements for Computer Systems Validation (CSV) at (insert name of company

More information

Author s job title Head of Clinical Coding and Data Quality Directorate IM&T

Author s job title Head of Clinical Coding and Data Quality Directorate IM&T Document Control Title Data Quality Policy Author Author s job title Head of Clinical Coding and Data Quality Directorate IM&T Department Clinical Coding Version Date Issued Status Comment / Changes /

More information

Information Governance Strategy and Management Framework

Information Governance Strategy and Management Framework Information Governance Strategy and Management Framework Summary: This strategy sets out the framework, structure, system and accountabilities for Information Governance Management within NHS Eastbourne,

More information

INFORMATION GOVERNANCE MANAGEMENT FRAMEWORK

INFORMATION GOVERNANCE MANAGEMENT FRAMEWORK INFORMATION GOVERNANCE MANAGEMENT FRAMEWORK Document History Document Reference: IG33 Document Purpose: The document complements all other Information Governance policies and sets out the management arrangements

More information

Combined trial of an investigational medicinal product and an investigational medical device

Combined trial of an investigational medicinal product and an investigational medical device Welcome to the Integrated Research Application System IRAS Project Filter The integrated dataset required for your project will be created from the answers you give to the following questions. The system

More information

A Guide to Efficient Trial Management. Trials Managers Network

A Guide to Efficient Trial Management. Trials Managers Network A Guide to Efficient Trial Management Trials Managers Network The Fourth Edition (2014) of the Guide to Efficient Trial Management was produced by an appointed Editorial Board and a dedicated group of

More information

Records Management Plan

Records Management Plan Records Management Plan Introduction Purpose The purpose of the Records Management Plan template enables a Business Unit to plan their records management activities based on the business units 1,2 or 3

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

Medical Device Directive

Medical Device Directive Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,

More information

"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia

From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia "From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia Damir Hamamdžić D.V.M., Ph.D. Office of Research Regulatory Affairs Rutgers University RWJMS

More information

NUH PHARMACY CLINICAL TRIALS. Sheila Hodgson, Lead Pharmacist, Clinical Trials June 30th 2014

NUH PHARMACY CLINICAL TRIALS. Sheila Hodgson, Lead Pharmacist, Clinical Trials June 30th 2014 NUH PHARMACY CLINICAL TRIALS Sheila Hodgson, Lead Pharmacist, Clinical Trials June 30th 2014 Dedicated pharmacy trials staff Lead Pharmacist, Service Co-ordinator Pharmacists: Band 7 and 8a Technicians:

More information

QUALITY SYSTEM PROCEDURES

QUALITY SYSTEM PROCEDURES 1/5 1.0 Purpose In accordance to ISO/TS 16949, American Mitsuba Corporation is responsible for the evaluation and selection of suppliers on their ability to supply products in accordance to customer requirements,

More information

Department At-A-Glance

Department At-A-Glance Integrated Site Services Functional Role Integrated Site Services (ISS) includes global and country Start-Up and Regulatory units (RSU) and Integrated Patients & Site Services (IPSS). Our department s

More information